drugset / Trial / NCT03982030
Dalbavancin Outpatient Pilot
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this research is to determine if a new antibiotic called dalbavancin will work to treat and cure certain infections while reducing the need for daily antibiotics by vein.
Timeline
- Start
- 2023-04
- Primary completion
- 2025-04
- Completion
- 2025-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dalbavancin | Other / unclassified | 1.5 g | Intravenous |